Iodobenzene

Iodobenzene

SCHEMBL18190267

Br.Ic1ccccc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Iodobenzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodobenzene SCHEMBL10616506 1.00 — —
Iodobenzene SCHEMBL1587 0.96 — —
Iodobenzene SCHEMBL10538620 0.96 ALDH1A1 (0.43) —
Iodobenzene SCHEMBL10481785 0.96 ALDH1A1 (0.43) —
Iodobenzene SCHEMBL3628957 0.96 — —
Iodobenzene SCHEMBL1331855 0.96 — —
Iodobenzene SCHEMBL10878191 0.92 — —
Iodobenzene SCHEMBL2250668 0.92 — —
Iodobenzene SCHEMBL4335131 0.92 ALDH1A1 (0.40) —
Iodobenzene SCHEMBL20608266 0.92 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3741392-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING DIAGNOSIS AND PHOTODYNAMIC THERAPY, AND PREPARATION METHOD THEREFOR Seoul National University R & DB Foundation (KR) 2020-11-25 — — EP claimed
CN-111954543-A Positron emission tomography radioactive tracer for translocator overexpression related diseases, translocator targeting ligand for fluorescence imaging diagnosis and photodynamic therapy and preparation method thereof 首尔国立大学校产学协力财团 2020-11-17 — — CN claimed
US-20200345870-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2020-11-05 — — US claimed
US-20260061083-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR SEOUL NATIONAL UNIVERSITY R&DB FOUNDATGON (KR) 2026-03-05 — — US disclosed
US-12491271-B2 Positron emission tomography radiotracer for diseases associated with translocator protein overexpression, translocator protein-targeting ligand for fluorescence imaging-guided surgery and photodynamic therapy, and production methods therefor SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2025-12-09 — — US disclosed
EP-3288735-B1 PROCESS FOR HALOGENATING OLEFINIC-DERIVED ELASTOMERS IN THE BULK PHASE EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-07-03 — — EP disclosed
US-20240156997-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2024-05-16 — — US disclosed
US-20220371253-A1 System and Process for Halogenating Olefinic-Derived Elastomers in the Bulk Phase EXXONMOBILE CHEMICAL PATENTS INC (US) 2022-11-24 — — US disclosed
US-10947375-B2 System and process for the production of functionalized olefinic-based polymer EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-03-16 — — US disclosed
EP-3408019-B1 SYSTEM AND PROCESS FOR THE PRODUCTION OF FUNCTIONALIZED OLEFINIC-BASED POLYMER EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-01-20 — — EP disclosed
EP-3741392-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING DIAGNOSIS AND PHOTODYNAMIC THERAPY, AND PREPARATION METHOD THEREFOR Seoul National University R & DB Foundation (KR) 2020-11-25 — — EP disclosed
US-20200345870-A1 POSITRON EMISSION TOMOGRAPHY RADIOTRACER FOR DISEASES ASSOCIATED WITH TRANSLOCATOR PROTEIN OVEREXPRESSION, TRANSLOCATOR PROTEIN-TARGETING LIGAND FOR FLUORESCENCE IMAGING-GUIDED SURGERY AND PHOTODYNAMIC THERAPY, AND PRODUCTION METHODS THEREFOR SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2020-11-05 — — US disclosed
US-20200255643-A1 System and Process for the Production of Functionalized Olefinic-Based Polymer EXXONMOBIL CHEMICAL PATENTS INC. 2020-08-13 — — US disclosed
CN-107548343-B System and process for halogenating olefin-derived elastomers in bulk phase 埃克森美孚化学专利公司 2020-06-09 — — CN disclosed
CN-108472618-B Systems and methods for producing functionalized olefin-based polymers 埃克森美孚化学专利公司 2020-04-28 — — CN disclosed
EP-3408019-A1 SYSTEM AND PROCESS FOR THE PRODUCTION OF FUNCTIONALIZED OLEFINIC-BASED POLYMER ExxonMobil Chemical Patents Inc. (US) 2018-12-05 — — EP disclosed
US-20180085989-A1 System and Process for Halogenating Olefinic-Derived Elastomers in the Bulk Phase EXXONMOBIL CHEMICAL PATENTS INC. 2018-03-29 — — US disclosed
EP-3288735-A1 SYSTEM AND PROCESS FOR HALOGENATING OLEFINIC-DERIVED ELASTOMERS IN THE BULK PHASE ExxonMobil Chemical Patents Inc. (US) 2018-03-07 — — EP disclosed
WO-2017131869-A1 SYSTEM AND PROCESS FOR THE PRODUCTION OF FUNCTIONALIZED OLEFINIC-BASED POLYMER EXXONMOBIL CHEMICAL PATENTS INC. (US) 2017-08-03 — — WO disclosed
WO-2016175938-A1 SYSTEM AND PROCESS FOR HALOGENATING OLEFINIC-DERIVED ELASTOMERS IN THE BULK PHASE EXXONMOBIL CHEMICAL PATENTS INC. (US) 2016-11-03 — — WO disclosed
Send feedback